Trial Outcomes & Findings for Improving Mental Health Outcomes: Building an Adaptive Implementation Strategy (NCT NCT02151331)

NCT ID: NCT02151331

Last Updated: 2018-12-12

Results Overview

Mental Health Quality of Life was measured using the 12-Item Short Form Survey (SF-12). The SF-12 has a scale range of 0-100 with higher values representing better outcomes.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

383 participants

Primary outcome timeframe

Change from Baseline in Quality of Life at 12-months

Results posted on

2018-12-12

Participant Flow

A total of 383 participants were consented and enrolled to participate. Of those 383 participants, only 169 were randomized participants from a non-responsive site.

Participant milestones

Participant milestones
Measure
REP + EF
Replication Effective Programs (REP) augmented with External Facilitation (EF) External Facilitation: Non-responding sites randomized to receive external facilitation
REP + EF/IF
Replicating Effective Programs (REP) augmented with External and Internal Facilitation (EF + IF) External + Internal Facilitation: Non-responding sites randomized to receive both internal and external facilitation
Overall Study
STARTED
77
92
Overall Study
COMPLETED
45
52
Overall Study
NOT COMPLETED
32
40

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Improving Mental Health Outcomes: Building an Adaptive Implementation Strategy

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
REP + EF
n=77 Participants
Replication Effective Programs (REP) augmented with External Facilitation (EF) External Facilitation: Non-responding sites randomized to receive external facilitation
REP + EF/IF
n=92 Participants
Replicating Effective Programs (REP) augmented with External and Internal Facilitation (EF + IF) External + Internal Facilitation: Non-responding sites randomized to receive both internal and external facilitation
Total
n=169 Participants
Total of all reporting groups
Age, Continuous
48.2 years
STANDARD_DEVIATION 11.14 • n=5 Participants
43.0 years
STANDARD_DEVIATION 11.19 • n=7 Participants
45.38 years
STANDARD_DEVIATION 11.43 • n=5 Participants
Sex: Female, Male
Female
54 Participants
n=5 Participants
71 Participants
n=7 Participants
125 Participants
n=5 Participants
Sex: Female, Male
Male
23 Participants
n=5 Participants
21 Participants
n=7 Participants
44 Participants
n=5 Participants
Race/Ethnicity, Customized
White
61 Participants
n=5 Participants
73 Participants
n=7 Participants
134 Participants
n=5 Participants
Race/Ethnicity, Customized
Not Available
16 Participants
n=5 Participants
19 Participants
n=7 Participants
35 Participants
n=5 Participants
Region of Enrollment
United States
77 participants
n=5 Participants
92 participants
n=7 Participants
169 participants
n=5 Participants
Mental Health Quality of Life
39.75 units on a scale
STANDARD_DEVIATION 12.92 • n=5 Participants
36.66 units on a scale
STANDARD_DEVIATION 13.10 • n=7 Participants
38.08 units on a scale
STANDARD_DEVIATION 13.07 • n=5 Participants
Mood Disorder Symptoms (PHQ-9)
11.45 units on a scale
STANDARD_DEVIATION 6.46 • n=5 Participants
12.61 units on a scale
STANDARD_DEVIATION 6.94 • n=7 Participants
12.08 units on a scale
STANDARD_DEVIATION 6.73 • n=5 Participants

PRIMARY outcome

Timeframe: Change from Baseline in Quality of Life at 12-months

Mental Health Quality of Life was measured using the 12-Item Short Form Survey (SF-12). The SF-12 has a scale range of 0-100 with higher values representing better outcomes.

Outcome measures

Outcome measures
Measure
REP + EF
n=45 Participants
Replication Effective Programs (REP) augmented with External Facilitation (EF) External Facilitation: Non-responding sites randomized to receive external facilitation
REP + EF/IF
n=52 Participants
Replicating Effective Programs (REP) augmented with External and Internal Facilitation (EF + IF) External + Internal Facilitation: Non-responding sites randomized to receive both internal and external facilitation
Health-related Quality of Life - Mental Health Component Score
2.14 score on a scale
Interval -0.22 to 4.5
-0.20 score on a scale
Interval -3.25 to 0.86

PRIMARY outcome

Timeframe: Change from Baseline in Mood Disorder Symptoms at 12-months

Mood disorder symptoms were measured using the Patient Health Questionnaire (9-question). The PHQ-9 has a scale range of 0-27 with lower values representing better outcomes.

Outcome measures

Outcome measures
Measure
REP + EF
n=45 Participants
Replication Effective Programs (REP) augmented with External Facilitation (EF) External Facilitation: Non-responding sites randomized to receive external facilitation
REP + EF/IF
n=52 Participants
Replicating Effective Programs (REP) augmented with External and Internal Facilitation (EF + IF) External + Internal Facilitation: Non-responding sites randomized to receive both internal and external facilitation
Reduced Mood Disorder Symptoms
-1.57 score on a scale
Interval -2.65 to -0.5
-1.02 score on a scale
Interval -2.02 to -0.01

SECONDARY outcome

Timeframe: Change from Baseline in Quality of Life at 24-months

Population: No analysis was completed because the funder requested terminating the study due to low enrollment. No data was collected because the study was halted prematurely.

Health-related Quality of Life - Mental Health Component Score of the short form (SF)-12 survey

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: Change from Baseline in Mood Disorder Symptoms at 24-months

Population: No analysis was completed because the funder requested terminating the study due to low enrollment. No data was collected because the study was halted prematurely.

Outcome measures

Outcome data not reported

Adverse Events

REP + EF

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

REP + EF/IF

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Amy Kilbourne, PhD

University of Michigan

Phone: 734-845-3452

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place